Biomarker Analysis and Updated Clinical Follow-Up from BLASST-1 (bladder Cancer Signal Seeking Trial) of Nivolumab, Gemcitabine, and Cisplatin in Patients with Muscle-Invasive Bladder Cancer (MIBC) Undergoing Cystectomy.
Journal of Clinical Oncology（2024）
Key words
227-149-9863,261-3278,283-183-138-226-11080,613-4678-146-11576,613-135-2370-7650,613-135-244-3829,227-149-9863-9995,3590,14,176,14,1704,38092-34807
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined